The following total costs were identified.
For children with mild or moderate body eczema (14-year horizon):
TCS alone, 387.31;
TCS followed by pimecrolimus, 474.82;
pimecrolimus followed by TCS, 1,958.57.
For children with mild or moderate face eczema (14-year horizon):
TCS alone, 270.71;
TCS followed by pimecrolimus, 461.45;
pimecrolimus followed by TCS, 788.64.
For adults with mild or moderate body eczema (1-year horizon):
TCS alone, 49.98;
TCS followed by pimecrolimus, 83.17;
pimecrolimus followed by TCS, 354.44.
For adults with mild or moderate face eczema (1-year horizon):
TCS alone, 38.65;
TCS followed by pimecrolimus, 69.17;
pimecrolimus followed by TCS, 132.87.